Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Income (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Operating Income for 13 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income fell 199.77% year-over-year to -$1.7 million, compared with a TTM value of -$7.6 million through Dec 2025, down 12.67%, and an annual FY2025 reading of -$4.2 million, up 64.45% over the prior year.
  • Operating Income was -$1.7 million for Q4 2025 at Neuroone Medical Technologies, down from -$1.4 million in the prior quarter.
  • Across five years, Operating Income topped out at $1.7 million in Q4 2024 and bottomed at -$3.5 million in Q2 2023.
  • Average Operating Income over 5 years is -$2.4 million, with a median of -$2.8 million recorded in 2022.
  • The sharpest move saw Operating Income skyrocketed 150.47% in 2024, then tumbled 199.77% in 2025.
  • Year by year, Operating Income stood at -$2.8 million in 2021, then soared by 36.48% to -$1.8 million in 2022, then plummeted by 90.01% to -$3.4 million in 2023, then surged by 150.47% to $1.7 million in 2024, then crashed by 199.77% to -$1.7 million in 2025.
  • Business Quant data shows Operating Income for NMTC at -$1.7 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.9 million in Q2 2025.